Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection

Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance. We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases. To examine the therapeutic efficacy of oral NSC61610 ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Leber, Andrew, Bassaganya-Riera, Josep, Tubau-Juni, Nuria, Zoccoli-Rodriguez, Victoria, Lu, Pinyi, Godfrey, Victoria, Kale, Shiv, Hontecillas, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318425/
https://www.ncbi.nlm.nih.gov/pubmed/28270815
http://dx.doi.org/10.3389/fimmu.2017.00178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318425/
https://www.ncbi.nlm.nih.gov/pubmed/28270815
http://dx.doi.org/10.3389/fimmu.2017.00178

Ejemplares similares